Biltmore Family Office’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.4M Sell
16,899
-526
-3% -$43.6K 0.24% 71
2025
Q1
$1.41M Sell
17,425
-735
-4% -$59.6K 0.24% 70
2024
Q4
$1.64M Sell
18,160
-996
-5% -$89.7K 0.27% 64
2024
Q3
$1.89M Buy
19,156
+1,009
+6% +$99.7K 0.32% 56
2024
Q2
$1.68M Buy
18,147
+725
+4% +$67.2K 0.31% 56
2024
Q1
$1.65M Buy
17,422
+2,461
+16% +$234K 0.33% 55
2023
Q4
$1.34M Sell
14,961
-15,031
-50% -$1.34M 0.28% 63
2023
Q3
$2.19M Buy
29,992
+1,950
+7% +$142K 0.5% 37
2023
Q2
$2.33M Buy
28,042
+778
+3% +$64.7K 0.49% 34
2023
Q1
$2.08M Sell
27,264
-4,217
-13% -$321K 0.44% 38
2022
Q4
$2.61M Buy
31,481
+4,246
+16% +$352K 0.54% 29
2022
Q3
$2.16M Buy
27,235
+6,679
+32% +$530K 0.49% 32
2022
Q2
$1.53M Sell
20,556
-7,281
-26% -$541K 0.38% 48
2022
Q1
$2.5M Sell
27,837
-12,477
-31% -$1.12M 0.54% 32
2021
Q4
$4.51M Buy
40,314
+36,722
+1,022% +$4.11M 0.86% 19
2021
Q3
$452K Sell
3,592
-420
-10% -$52.9K 0.11% 111
2021
Q2
$543K Sell
4,012
-67
-2% -$9.07K 0.15% 94
2021
Q1
$553K Buy
4,079
+157
+4% +$21.3K 0.17% 87
2020
Q4
$552K Buy
3,922
+462
+13% +$65K 0.17% 83
2020
Q3
$386K Sell
3,460
-377
-10% -$42.1K 0.22% 93
2020
Q2
$430K Buy
3,837
+107
+3% +$12K 0.26% 90
2020
Q1
$289K Sell
3,730
-887
-19% -$68.7K 0.19% 111
2019
Q4
$439K Sell
4,617
-47,929
-91% -$4.56M 0.18% 108
2019
Q3
$4.01M Sell
52,546
-235
-0.4% -$17.9K 1.73% 14
2019
Q2
$4.63M Buy
52,781
+5,615
+12% +$492K 2.51% 7
2019
Q1
$4.27M Buy
47,166
+3,520
+8% +$319K 2.17% 9
2018
Q4
$3.13M Buy
43,646
+12,419
+40% +$891K 1.77% 16
2018
Q3
$2.99M Sell
31,227
-55
-0.2% -$5.27K 1.43% 24
2018
Q2
$2.98M Buy
31,282
+10,752
+52% +$1.02M 1.48% 22
2018
Q1
$1.8M Buy
+20,530
New +$1.8M 0.8% 40